Last: | $86.22 |
---|---|
Change Percent: | 1.18% |
Open: | $84.07 |
Close: | $86.22 |
High: | $86.3 |
Low: | $83.6 |
Volume: | 238,822 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$86.22 | $84.07 | $86.22 | $86.3 | $83.6 | 238,822 | 04-24-2024 |
$85.07 | $84.2 | $85.07 | $85.84 | $83.685 | 231,275 | 04-23-2024 |
$83.62 | $81.52 | $83.62 | $83.854 | $80.9 | 402,130 | 04-22-2024 |
$81.24 | $83.32 | $81.24 | $83.32 | $80.15 | 845,073 | 04-19-2024 |
$83.46 | $85.14 | $83.46 | $86.14 | $82.89 | 966,385 | 04-18-2024 |
$84.88 | $84.26 | $84.88 | $85.45 | $84.06 | 359,409 | 04-17-2024 |
$84.17 | $84.36 | $84.17 | $84.915 | $83.635 | 273,091 | 04-16-2024 |
$84.88 | $85.39 | $84.88 | $86.24 | $84.86 | 318,187 | 04-15-2024 |
$85.22 | $85.98 | $85.22 | $86.22 | $84.67 | 395,113 | 04-12-2024 |
$86.52 | $86.8 | $86.52 | $86.8 | $85.82 | 402,449 | 04-11-2024 |
$86.15 | $86.25 | $86.15 | $87.34 | $85.635 | 398,286 | 04-10-2024 |
$87.06 | $85.89 | $87.06 | $87.11 | $85.67 | 307,288 | 04-09-2024 |
$85.32 | $84.9 | $85.32 | $85.58 | $84.61 | 234,853 | 04-08-2024 |
$84.65 | $84.76 | $84.65 | $85.29 | $84.241 | 272,372 | 04-05-2024 |
$84.89 | $84.73 | $84.89 | $86.035 | $84.445 | 384,690 | 04-04-2024 |
$83.92 | $83.67 | $83.92 | $84.69 | $83.23 | 532,896 | 04-03-2024 |
$84.17 | $83.58 | $84.17 | $85.08 | $83.13 | 510,381 | 04-02-2024 |
$84.79 | $85.72 | $84.79 | $86.115 | $83.67 | 355,019 | 04-01-2024 |
$85.35 | $83.92 | $85.35 | $85.45 | $83.67 | 593,876 | 03-29-2024 |
$85.35 | $83.92 | $85.35 | $85.45 | $83.67 | 593,876 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Haemonetics Corporation Company Name:
HAE Stock Symbol:
NYSE Market:
Haemonetics Corporation Website:
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024 PR Newswire BOSTON , April 10, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2024...
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge PR Newswire BOSTON , April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions...
Haemonetics Corporation Completes Acquisition of Attune Medical PR Newswire BOSTON , April 1, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive bette...